Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

So depression is an inflammatory disease, but where does the inflammation come from?

Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M.

BMC Med. 2013 Sep 12;11:200. doi: 10.1186/1741-7015-11-200. Review.

2.
3.

Sleep disturbance, inflammation and depression risk in cancer survivors.

Irwin MR, Olmstead RE, Ganz PA, Haque R.

Brain Behav Immun. 2013 Mar;30 Suppl:S58-67. doi: 10.1016/j.bbi.2012.05.002. Epub 2012 May 24. Review.

4.

Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.

Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J.

Neuro Endocrinol Lett. 2011;32(1):7-24. Review.

PMID:
21407167
5.

Role of Adiposity-Driven Inflammation in Depressive Morbidity.

Capuron L, Lasselin J, Castanon N.

Neuropsychopharmacology. 2017 Jan;42(1):115-128. doi: 10.1038/npp.2016.123. Epub 2016 Jul 11. Review.

6.

Inflammation: depression fans the flames and feasts on the heat.

Kiecolt-Glaser JK, Derry HM, Fagundes CP.

Am J Psychiatry. 2015 Nov 1;172(11):1075-91. doi: 10.1176/appi.ajp.2015.15020152. Epub 2015 Sep 11. Review.

PMID:
26357876
7.

Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways.

Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M.

CNS Spectr. 2016 Apr;21(2):184-98. doi: 10.1017/S1092852915000449. Epub 2015 Aug 26. Review.

PMID:
26307347
8.

Oxidative & nitrosative stress in depression: why so much stress?

Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA, Anderson G, Jacka FN, Maes M.

Neurosci Biobehav Rev. 2014 Sep;45:46-62. doi: 10.1016/j.neubiorev.2014.05.007. Epub 2014 May 21. Review.

PMID:
24858007
10.

Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.

Maes M, Mihaylova I, Kubera M, Ringel K.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):169-75. doi: 10.1016/j.pnpbp.2011.09.006. Epub 2011 Sep 16.

PMID:
21945535
11.

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Maes M, Nowak G, Caso JR, Leza JC, Song C, Kubera M, Klein H, Galecki P, Noto C, Glaab E, Balling R, Berk M.

Mol Neurobiol. 2016 Jul;53(5):2927-2935. doi: 10.1007/s12035-015-9183-5. Epub 2015 May 2. Review.

PMID:
25934103
12.

The complex interplay of Depression, Inflammation and Omega-3: state of the art and progresses in research.

Mazza M, Marano G, Traversi G, Di Nicola M, Catalano V, Janiri L.

Clin Ter. 2015;166(3):e242-7. doi: 10.7417/T.2015.1859. Review.

PMID:
26152637
13.

A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise.

Lopresti AL, Hood SD, Drummond PD.

J Affect Disord. 2013 May 15;148(1):12-27. doi: 10.1016/j.jad.2013.01.014. Epub 2013 Feb 14. Review.

PMID:
23415826
14.

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.

Anderson G, Maes M, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:101-14. doi: 10.1016/j.pnpbp.2012.07.016. Epub 2012 Aug 22. Review.

PMID:
22930036
15.

Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders.

Talarowska M, Bobińska K, Zajączkowska M, Su KP, Maes M, Gałecki P.

Med Sci Monit. 2014 Jan 24;20:110-5. doi: 10.12659/MSM.889853.

16.

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.

Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):769-83. doi: 10.1016/j.pnpbp.2010.06.008. Epub 2010 Jun 16. Review.

PMID:
20561554
17.

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

Maes M, Anderson G, Kubera M, Berk M.

Expert Opin Ther Targets. 2014 May;18(5):495-512. doi: 10.1517/14728222.2014.888417. Epub 2014 Feb 19. Review.

PMID:
24548241
18.

Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.

Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SO, Berk M, Dodd S, Maes M.

J Affect Disord. 2014 Apr;159:23-30. doi: 10.1016/j.jad.2014.02.018. Epub 2014 Feb 19.

PMID:
24679385
19.

IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology.

Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M.

J Affect Disord. 2011 Dec;135(1-3):414-8. doi: 10.1016/j.jad.2011.08.023. Epub 2011 Sep 17.

PMID:
21930301
20.

Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment.

Lopresti AL, Drummond PD.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:92-9. doi: 10.1016/j.pnpbp.2013.05.005. Epub 2013 May 14. Review.

PMID:
23685202

Supplemental Content

Support Center